
Arazex-S 1.5 Injection
Marketer
Cospex Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Arazex-S 1.5 Injection
Combiflox-1.5 Injection is a dual-action medication used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curtailing infection spread. Administration must be overseen by a qualified healthcare provider. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise therapeutic efficacy. Potential side effects include, but are not limited to, nausea, emesis, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical consultation. Seek immediate medical attention for any allergic reaction manifesting as rash, pruritus, edema, or dyspnea. Prior to commencing treatment, disclose all current medications and pre-existing conditions to your physician. This includes informing your doctor if you are pregnant or breastfeeding. Alcohol consumption should be avoided due to the potential for increased somnolence. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Optimal recovery involves adequate rest, a nutritious diet, and sufficient hydration. Your physician may order laboratory and imaging studies to monitor treatment response.
Primary Ingredients of Arazex-S 1.5 Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Arazex-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Arazex-S 1.5 Injection:
Administering this medication will be performed by your physician or their qualified nursing staff; self-medication is strictly prohibited.
Common Side effects of Arazex-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Arazex-S 1.5 Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Arazex-S 1.5 Injection works:
The injectable formulation Arazex-S 1.5 combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Arazex-S 1.5 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Arazex-S 1.5 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administration of Arazex-S 1.5 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Arazex-S 1.5 Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Arazex-S 1.5 Injection's use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Administering Arazex-S 1.5 Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Arazex-S 1.5 Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Arazex-S 1.5 Injection :
Omitting a scheduled Arazex-S 1.5 Injection dose necessitates contacting your physician.
Facts to Know About Arazex-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
